An observational study in Sarcopenia and Nerve Block, sponsored by Chang Gung Memorial Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Chang Gung Memorial Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Sarcopenia by Chang Gung Memorial Hospital — 8 open to participants now, 8 under way, none of them phase 3. Sarcopenia · Chang Gung Memorial Hospital.
Among the 14 studies in Sarcopenia by Chang Gung Memorial Hospital, this one is one of 2 that started in 2026, is one of 3 observational ones, and was the 13th registered.
1,333 studies on the registry are indexed under Sarcopenia; 419 are open to participants now.
Browse Sarcopenia studies →8 of the 14 studies in Sarcopenia by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 50–99
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–80
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20+ · Healthy volunteers
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 65+
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 50+
By country, each count listing its studies:
Of the 247 Sarcopenia studies recruiting now, 154 (62%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 50 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 150 is above the median of 120 across 455 observational studies indexed under Sarcopenia.
Median enrollment 90 across the 11 interventional studies, 150 across the 3 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.
3 of the studies in Sarcopenia by Chang Gung Memorial Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07896603Chang Gung Memorial HospitalPhysical Activity Interventions for Sleep Improvement and Sedative-Hypnotic Reduction in Middle-Aged and Older Adults: Investigating the Role of Sarcopenia | 2027-07 |
| NCT07180134Chang Gung Memorial HospitalHealth Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients | 2027-07-31 |
| NCT06666881Chang Gung Memorial HospitalSkeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients | 2027-09-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 14 studies in Sarcopenia by Chang Gung Memorial Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to learn about the impact of sarcopenia (muscle loss) on the efficacy of regional nerve blocks and postoperative recovery in patients undergoing upper extremity surgery. The main questions it aims to answer are:
Participants will undergo a preoperative muscle assessment, which includes a chair stand test and a brief ultrasound of the thigh muscle. Researchers will then observe and record their nerve block onset time (if applicable), postoperative pain scores, and recovery metrics during their hospital stay up to postoperative day 2.
The study population comprises patients aged 50 years and older with an American Society of Anesthesiologists (ASA) physical status of I to III, who are scheduled to undergo upper extremity surgery under general anesthesia. Eligible participants must be capable of cooperating with postoperative pain and functional assessments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: sarcopenia · Other: Non-sarcopenia · Procedure: General Anesthesia
Other: sarcopenia · Procedure: General Anesthesia · Procedure: Nerve Block
Other: Non-sarcopenia · Procedure: General Anesthesia · Procedure: Nerve Block
Patients identified with sarcopenia based on preoperative muscle assessment.
Patients with normal muscle mass based on preoperative muscle assessment.
received general anesthesia alone
general anesthesia combined with nerve block
time to first rescue analgesia
Time frame: From the completion of surgery up to Postoperative Day 2
Nerve block onset
Time frame: From the completion of local anesthetic injection up to 30 minutes
Nerve block duration
Time frame: From the successful onset of sensory block to the patient's first report of pain at the surgical site, assessed up to postoperatively day 2
Intraoperative Mean Arterial Pressure (MAP) and Heart Rate (HR)
Mean Arterial Pressure (MAP) measured in mmHg and Heart Rate (HR) measured in beats per minute, assessed continuously using standard non-invasive or invasive hemodynamic monitors.
Time frame: During surgery (From the induction of anesthesia to the end of surgery, an average of 2 hours)
Postoperative NRSFrom the end of surgery up to 48 hours postoperatively.
Time frame: From the end of surgery up to postoperative day 2
Total opioid consumption
Time frame: From the end of surgery up to postoperative day 2
Incidence of Local Anesthetic Systemic Toxicity (LAST)
LAST is defined as the occurrence of adverse central nervous system signs (e.g., altered mental status, seizures, tinnitus) or cardiovascular signs (e.g., arrhythmias, profound hypotension, cardiac arrest) following the administration of local anesthetics. It will be assessed clinically by the attending anesthesiologist and recorded as a binary outcome (Yes/No).
Time frame: From the initiation of nerve block up to 24 hours postoperatively
Incidence of postoperative delirium
The incidence of postoperative delirium will be assessed using the Confusion Assessment Method (CAM). The CAM diagnostic algorithm evaluates four features: (1) acute onset and fluctuating course, (2) inattention, (3) disorganized thinking, and (4) altered level of consciousness. Delirium is considered present if features 1 and 2 are observed, along with either feature 3 or 4. The outcome will be recorded as a binary variable (Yes/No).
Time frame: From the end of surgery up to postoperative day 2
ICU stay
Time frame: From ICU admission up to postoperative day 2
Started Sep 2026 (actual). Primary completion is estimated for Aug 2028, 23 months after the start.
Of 191 non-industry observational studies under Sarcopenia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 63. This study's planned 23 months is below that.
Counting every sponsor, half of 193 studies reached it within 26 months; a quarter within 12 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital →